Notable healthcare headlines for the week: Merck, Novo Nordisk, J&J and Roche in focus
Discover last week's top S&P 500 healthcare gainers, major market stories, and groundbreaking pharma deals, including weight-loss drug updates.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors To Secure Counsel Before Important Deadline In Securities Class Action MRK
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the“Class ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Merck & Co.
Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Merck & Co., Inc. (“Merck” or the“Company”) (NYSE: MRK) and reminds investors of the April 14, ...